Abu Dhabi – Mubasher: Burjeel Holdings has teamed up with Northwell Health, a healthcare provider in the US, to launch an advanced Neuroscience Institute in Abu Dhabi.
The partnership comes in line with Burjeel’s plans to bring complex care and enlarge the flow of international patients to the UAE, according to a press release.
Meanwhile, the institute will be located at Burjeel Medical City (BMC) and will secure care for adult and pediatric patients with neurological disorders, including autoimmune brain disorders, epilepsy, Parkinson’s and movement disorders, pediatric neurology, and multiple sclerosis.
Souhel Najjar, Executive Director and Senior Vice President of the Northwell Health Neurology Service Line, will head the institute in Abu Dhabi.
Michael J. Dowling, President and CEO of Northwell Health, said: “This collaboration is an exciting opportunity to provide world-class care to the communities of Abu Dhabi.”
John Sunil, CEO of Burjeel Holdings, noted: “The partnership is another important step in Burjeel Holdings’ commitment to delivering unmatched healthcare excellence in the region and greatly improving patient outcomes.”
“The collaboration with Northwell Health and Dr. Najjar aligns with the group’s endeavors to provide complex care and access to the newest treatments and technologies for patients across the region,” Sunil added.
In the first quarter (Q1) of 2023, the ADX-listed company recorded an annual jump in net profit attributable to the owners at AED 118.79 million from AED 82.16 million.
